McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
Follow MCK
McKesson Corporation (MCK) Book value per share
McKesson Corporation's book value per share at the end of fiscal 2026 was −14.4×, compared with −13.3× in fiscal 2025. At the end of the quarter to 30 June 2026 it was −32.6×. Over the past ten years it has ranged from −14.4× (fiscal 2026) to 51.0× (fiscal 2017) — the current reading is the lowest in ten years. McKesson Corporation ranks 11th of 11 Medical Distribution companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | −14.4× | — |
| FY2025 | −13.3× | — |
| FY2024 | −12.0× | — |
| FY2023 | −10.6× | — |
| FY2022 | −11.8× | — |
| FY2021 | 1.1× | (96.29%) |
| FY2020 | 29.4× | (30.37%) |
| FY2019 | 42.2× | (12.69%) |
| FY2018 | 48.4× | (5.21%) |
| FY2017 | 51.0× | 30.24% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | −32.6× | — |
| Mar 2026 | −14.4× | — |
| Dec 2025 | −7.3× | — |
| Sep 2025 | −10.9× | — |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| HSIC Henry Schein, Inc. compare | 33.6× |
| COR Cencora, Inc. compare | 16.8× |
| COSM Cosmos Health Inc. compare | 0.3× |
| AHG Akso Health Group Sponsored ADR compare | 0.0× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.0× |
| FOCL FocalTherics compare | −0.1× |
| ACH Accendra Health, Inc. compare | −7.2× |
| CAH Cardinal Health, Inc. compare | −11.5× |
| MCK McKesson Corporation | −32.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on MCK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement